About
Sola Bio develops gene therapies using its proprietary JUMP70 platform to restore the natural protein-folding machinery of cells and selectively eliminate misfolded proteins that cause neurodegenerative and conformational diseases such as ALS, Huntington's, and Alzheimer's disease.
Explore Sola Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.